HYGIEIA. REFORMING INSULIN THERAPY AS WE KNOW IT.
We are Hygieia. And we are singularly focused on revolutionizing how people manage their insulin. Using science, research and technology, we developed a breakthrough and highly effective insulin management program that not only changes how patients and physicians manage insulin today, but also establishes the standard of autonomous insulin dose adjustment.
With over seven million Americans with type 2 diabetes using insulin and only 33% achieving successful results, the need for a monumental shift in insulin management has never been greater. Hygieia’s founders, Dr. Eran Bashan and Dr. Israel Hodish answer the call with d-Nav Technology2 — an FDA-cleared breakthrough insulin management tool designed to significantly improve and simplify insulin treatment so that more people who are on insulin therapy succeed.
From inception, it has been our mission to redefine the way the world manages insulin, and we are committed to leading the charge.
Eran Bashan, PhD
CEO & Chairman of the Board
Israel Hodish, MD, PhD
Co-founder & Medical Director
Chief Technology Officer
Vice President of Research & Development
Vice President of Finance
Vice President of Business Development
Head of International Business Development
BOARD OF DIRECTORS
Richard M. Bergenstal, MD
George Grunberger, MD
Mark Fendrick, MD
Michael J. Miller, MD
Discover important news about d-Nav and type 2 diabetes.
Let us know if
we can help.